BSN medical GmbH, a leading global player in the medical device industry, is headquartered in Germany. Founded in 2001, the company has established itself as a key provider of innovative wound care, compression therapy, and orthopaedic solutions. With a strong presence across Europe, North America, and Asia, BSN medical is renowned for its commitment to quality and patient-centric products. The company’s core offerings include advanced wound dressings, compression bandages, and orthopaedic supports, all designed to enhance healing and improve patient outcomes. BSN medical's unique approach combines cutting-edge technology with a deep understanding of clinical needs, positioning it as a trusted partner in healthcare. Notable achievements include numerous industry awards and a robust market presence, solidifying its reputation as a leader in the medical sector.
How does BSN medical GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
BSN medical GmbH's score of 80 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
BSN medical GmbH, headquartered in Germany, currently does not have specific carbon emissions data available for the most recent year. However, the company is part of a corporate family that includes Essity AB (publ), from which it inherits emissions data and climate commitments. As a current subsidiary of Essity AB, BSN medical GmbH aligns with the sustainability initiatives and targets set by its parent company. Essity has established science-based targets (SBTi) aimed at reducing greenhouse gas emissions across its operations. These targets are cascaded down to BSN medical GmbH, ensuring that the subsidiary contributes to the overall climate goals of the group. While specific reduction targets for BSN medical GmbH are not detailed, the commitment to sustainability is evident through its association with Essity's broader climate strategies, which include initiatives to reduce Scope 1, 2, and 3 emissions. The company is actively engaged in efforts to enhance its environmental performance, although precise figures and specific commitments for BSN medical GmbH remain unspecified at this time. In summary, while BSN medical GmbH does not report its own emissions data, it is committed to climate action through the frameworks established by Essity AB, reflecting a dedication to reducing its carbon footprint in line with industry standards.
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 1,539,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | 1,819,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 3 | 7,053,000,000 | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | - |
BSN medical GmbH's Scope 3 emissions, which decreased by 8% last year and decreased by approximately 13% since 2016, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 71% of total emissions under the GHG Protocol, with "End-of-Life Treatment of Sold Products" being the largest emissions source at 31% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
BSN medical GmbH has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.